Optimal equations for describing the relationship between prostate volume, number of sources, and total activity in permanent prostate brachytherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 2, 2010, Pages 164-167

  Aronowitz, Jesse N ^a   Michalski, Jeff M ^b   Merrick, Gregory S ^c   Sylvester, John E ^d   Crook, Juanita M ^e,f   Butler, Wayne M ^c   Mawson, Christie ^f   Pratt, David ^b   Naidoo, Devi ^d   Karolczuk, Kathryn ^g  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WHEELING JESUIT UNIVERSITY   (United States)

^d Seattle Prostate Institute   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g Quality Assurance Review Center   (United States)

Author keywords

Brachytherapy; Dosimetry; Prostatic neoplasms

Indexed keywords

IODINE 125; PALLADIUM 103;

ANALYTICAL ERROR; ARTICLE; BRACHYTHERAPY; HUMAN; HUMAN TISSUE; IMPLANT; MATHEMATICAL COMPUTING; ORGAN SIZE; PRACTICE GUIDELINE; PROSTATE; PROSTATE VOLUME; RADIATION DOSE; RADIOACTIVITY;

BRACHYTHERAPY; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77951086253     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31819d3684     Document Type: Article

References (17)

1. D'Souza WD, Lee HK, Palmer MB, et al. Is intraoperative nomogram-based overplanning of prostate implants necessary? Int J Radiat Oncol Biol Phys. 2003;56:462-467.
2. Wu A, Lee CC, Johnson M, et al. A new power law for determination of total I-125 seed activity for ultrasound-guided prostate implants: clinical evaluations. Int J Radiat Oncol Biol Phys. 2000;47:1397-1403.
3. Anderson LL, Moni JV, Harrison LB. A nomograph for permanent implants of palladium-103 seeds. Int J Radiat Oncol Biol Phys. 1993;27:129-135.
4. Stone NN, Stock RG. Brachytherapy for prostate cancer: real-time threedimensional interactive seed implantation. Tech Urol. 1995;1:72-80.
5. Yu Y, Schell MC. A genetic algorithm for the optimization of prostate implants. Med Phys. 1996;23:2085-2091.
6. Wang XH, Potters L. A theoretical derivation of the nomograms for permanent prostate brachytherapy. Med Phys. 2001;28:683-687. (Pubitemid 32323320)
7. Al-Qaisieh B, Brearley E, St Clair S, et al. A study of a pretreatment method to predict the number of I-125 seeds required for prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;65:304-307.
8. Janeway HH. The use of buried emanation in the treatment of malignant tumors. Am J Roentgenol. 1920;7:325-327.
9. Henschke UK, Cevc P. Dimension averaging a simple method for dosimetry of interstitial implants. Radiobiol Radiother (Berl). 1968;9:287-298.
10. Anderson LL. Spacing nomograph for interstitial implants of I-125 seeds. Med Phys. 1976;3:48-51.
11. Cohen GN, Amols HI, Zelefsky MJ, et al. The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitioners. Int J Radiat Oncol Biol Phys. 2002;53:504-511.
12. Stock RG, Stone NN, Wesson MF, et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys. 1995;32:219-225.
13. McNeely LK, Stone NN, Presser J, et al. Influence of prostate volume on dosimetry results in real-time I-125 seed implantation. Int J Radiat Oncol Biol Phys. 2004;58:292-299.
14. Bice WS, Prestidge BR, Grimm PD, et al. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;41:921-927.
15. Merrick GS, Butler WM, Wallner KE, et al. Variability of prostate brachytherapy preimplant dosimetry: a multi-institutional analysis. Brachytherapy. 2004;4:241-251.
16. Aronowitz JN, Crook JM, Michalski JM, et al. Inter-institutional variation of implant activity for permanent prostate brachytherapy. Brachytherapy. 2008; 7:297-300.
17. Kudchadker RK, Swanson DA, Kuban DA, et al. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Int J Radiat Oncol Biol Phys. 2008;72:623-627